Newsroom


May 16, 2006

Dear Friend:

We are pleased to provide you with an MMRC Update. This briefing was created to keep you informed of the MMRC's progress toward its ultimate goal of accelerating drug development and improving patient outcomes in multiple myeloma.

We hope that you find this newsletter informative and we welcome any feedback you may have.

For more information, contact us at info@themmrc.org

The Multiple Myeloma Genomics Initiative was featured in the article, "Foundation Drives Research Agenda for Multiple Myeloma," published in the May 3, 2006, issue of the Journal of the National Cancer Institute. Author Karyn Hede writes that the MMRC’s Multiple Myeloma Genomics Initiative is recognized as being "ahead of the curve" and as setting its own agenda for effective and efficient collaboration in mapping the myeloma genome.

The MMRC was invited to speak at the 2006 Milken Institute Global Conference to discuss the importance of philanthropy in building innovative research models, such as the MMRC. MMRC CEO Kathy Giusti served on a panel alongside Lance Armstrong, tour de France champion and cancer survivor, Eli Broad, Founder of The Broad Foundation, Michael Milken, Chairman of the Milken Institute, and Carl Schramm, President and CEO of the Ewing Marion Kauffman Foundation. The MMRC was also invited to the Health Research Alliance's 2006 National Conference to present best practices and lessons learned in the development of the MMRC at the session, "Building Research Networks and Funding Teams."

The MMRC Tissue Bank has now accrued more than 600 myeloma patient bone marrow aspirates and matched peripheral blood samples under stringent Good Laboratory Practices (GLPs) and under the governance of more than 60 Standard Operating Procedures (SOPs). These high-quality tissue samples are now being used to advance critical research efforts, including pre-clinical validation studies and the flagship Multiple Myeloma Genomics Initiative. As such, the MMRC Tissue Bank was recently profiled as a model in biobanking in the article, "Standardized Tissue Collection Could Propel Cancer Research," published in the March 31, 2006, issue of CR Magazine.